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Abstract Cerebrovascular and cardiovascular diseases
are the leading causes of death and disability worldwide.
They are complex disorders resulting from the interplay of
genetic and environmental factors, and may share several
susceptibility genes. Several recent studies have implicated
variants of the Kalirin (KALRN) gene with susceptibility to
cardiovascular and metabolic phenotypes, but no studies
have yet been performed in stroke patients. KALRN is
involved, among others, in the inhibition of inducible nitric
oxide synthase, in the regulation of ischemic signal trans-
duction, and in neuronal morphogenesis, plasticity, and sta-
bility. The goal of the present study was to determine
whether SNPs in the KALRN region on 3q13, which
includes the Ropporin gene (ROPN1), predispose to ische-
mic stroke (IS) in a cohort of Portuguese patients and con-
trols. We genotyped 34 tagging SNPs in the KALRN and
ROPN1 chromosomal region on 565 IS patients and 517
unrelated controls, and performed genotype imputation for
405 markers on chromosome 3. We tested the single-
marker association of these SNPs with IS. One SNP
(rs4499545) in the ROPN1–KALRN intergenic region and
two SNPs in KALRN (rs17286604 and rs11712619) showed
signiWcant (P < 0.05) allelic and genotypic (unadjusted and
adjusted for hypertension, diabetes, and ever smoking)
association with IS risk. Thirty-two imputed SNPs also
showed an association at P < 0.05, and actual genotyping of
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rs11712039) validated their association. Furthermore,
rs11712039 was associated with IS (0.001 < P < 0.01) in a
recent well-powered genomewide association study (Ikram
et al. 2009). These studies suggest that variants in the
KALRN gene region constitute risk factors for stroke and
that KALRN may represent a common risk factor for vascu-
lar diseases.
Introduction
Cerebrovascular diseases, such as stroke, and cardiovascu-
lar diseases, such as coronary artery disease (CAD) and
myocardial infarction (MI), are among the top three leading
causes of death and disability worldwide (Murray and
Lopez 1997). They are complex disorders resulting from
the interplay of genetics and environment, and they share
many risk factors, including age, sex, hypertension, dyslipi-
demia, diabetes, obesity, smoking, and physical inactivity.
These atherothrombotic diseases most likely also share
common pathogenic mechanisms such as inXammation and
appear to have common susceptibility loci. For instance, a
locus on 9p21 has been Wrmly associated with vascular
pathologies such as heart disease, stroke, aneurysms, and
atherosclerosis (Matarin et al. 2008; Larson et al. 2007;
McPherson et al. 2007; Helgadottir et al. 2007, 2008; Kar-
vanen et al. 2009; O’Donnell et al. 2007; Ye et al. 2008).
The GENECARD study for early-onset CAD (Hauser
et al. 2004), the Diabetes Heart Study (DHS) for cardiovas-
cular disease (CVD), type 2 diabetes (T2D) and metabolic
syndrome (MS) (Bowden et al. 2006), and a meta-analysis
of four linkage studies for coronary heart disease (Chiodini
and Lewis 2003) identiWed linkage peaks on chromosome
3q. Ordered subset analysis signiWcantly increased the evi-
dence for linkage at 3q13 (LOD = 5.10, P = 0.008) in
GENECARD families with lower-risk lipid proWles and
fewer risk factors (Shah et al. 2006), and subsequent peak-
wide association mapping led to the identiWcation of twelve
SNPs in the Ropporin (ROPN1, OMIM 611757) and
KALRN (OMIM 604605) genes associated with early-onset
CAD (Wang et al. 2007). Validation in additional datasets
revealed that SNP rs9289231 in the Wrst intron of a KALRN
alternative transcript was associated with early-onset CAD
in all white data sets examined, and the risk allele of this
SNP was associated with atherosclerosis burden in human
aortas (Wang et al. 2007). Additionally, follow-up of the
DHS 3q linkage peak revealed that the KALRN polymor-
phism rs4234218 is associated with T2D, MS, and com-
bined phenotype (T2D + MS + CVD + coronary calciWed
plaque) (Rudock et al. 2008).
Furthermore, a recent and well-powered genomewide
association study (GWAS) conducted on four European
and American cohorts including 1,164 ischemic stroke
patients and 18,058 controls (Ikram et al. 2009) showed
that several polymorphisms in Kalirin are associated with
IS (0.001 < P < 0.01), even though below the genomewide
signiWcance level.
Kalirin is an extremely large gene with 60 exons span-
ning over 620 kb, characterized by multiple promoters pro-
ducing developmentally regulated isoforms predominantly
expressed in the brain (McPherson et al. 2004). KALRN
encodes for a guanine nucleotide exchange factor (GEF)
that activates Rho proteins, and is therefore a multifunc-
tional protein involved, among others, in neuronal morpho-
genesis and secretory granule maturation (Ferraro et al.
2007; Rabiner et al. 2005). Additionally, Kalirin may have
a neuroprotective role by inhibiting inducible nitric-oxide
synthase (iNOS) activity (Ratovitski et al. 1999), and par-
ticipates in the regulation of ischemic signal transduction
(Beresewicz et al. 2008).
The goal of the present study was to conWrm if SNPs in
the ROPN1–KALRN region predispose to ischemic stroke
(IS).
Patients and methods
Study subjects
Five-hundred sixty-Wve unrelated patients with a clinical
diagnosis of IS, who were under the age of 65 at stroke
onset, were recruited through Neurology and Internal Med-
icine Departments throughout Portugal. Stroke was deWned
by the presence of a new focal neurological deWcit, with an
acute onset and with symptoms and signs persisting for
more than 24 h. The stroke was conWrmed in all patients by
a computed tomography scan in 97% of cases and/or mag-
netic resonance imaging in 25% of patients. All patients
were seen, and all neuroradiology tests were reviewed by
study neurologists. Trauma, tumors, infection, and other
causes of neurological deWcit were excluded.
Data collection forms were developed for this study that
included extensive clinical information such as stroke char-
acteristics, general clinical observation, neurological symp-
toms and signs, complications and interventions during
hospitalization, and situation at discharge. Data were also
collected on relevant lifestyle aspects and previous clinical
risk factors.
Five-hundred seventeen unrelated healthy individuals
were included in this study as a control sample population.
Since stroke is a late-onset disease, the control group was
selected from a group of healthy volunteers with a higher
mean age than the case group, thus minimizing the chances
for mis-classiWcation as “stroke-free”. Control individuals
were veriWed to be free of stroke by direct interview before123
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The interview also included questions on established clini-
cal and lifestyle risk factors for stroke. All participants
were adults of Portuguese Caucasian origin.
The research protocol was approved by the Ethics Com-
mittees of participating institutions, and all participants pro-
vided informed consent.
SNP selection and genotyping
All SNPs originally found associated with CAD in the
CATHGEN initial dataset (Wang et al. 2007) were geno-
typed Wrst and then additional haplotype tagging SNPs
were included in the study. Genotypes of 30 European
(CEU) family trios were downloaded from the HapMap
Release 21/phaseII Jul06, on NCBI B35 assembly, and hap-
lotype tagging SNPs in the ROPN1–KALRN region were
identiWed in Haploview 4.0 (Barrett et al. 2005) with the
following options: pairwise mode, r2 > 0.8, and minor
allele frequency (MAF) >0.1. A total of 34 SNPs were gen-
otyped in a 384-well format, 31 of which using Seque-
nom’s (San Diego, USA) iPlex assay (primer extension of
multiplex products with detection by matrix-assisted laser
desorption/ionization time-of-Xight mass spectrometry) fol-
lowing manufacturer’s protocol and detected in a Seque-
nom MassArray K2 platform. The primer sequences are
available upon request and were designed using Seque-
nom’s MassARRAY® Assay Design 3.0. Extensive quality
control was performed using eight HapMap controls of
diverse ethnic aYliation, sample duplication within and
across plates, non-Mendelian inheritance check in three
large pedigrees, Hardy–Weinberg equilibrium (HWE) in
the control group (P > 0.05), and a minimum of 90% call rate.
Genotype determinations were performed blinded to aVection
status. The SNPs which failed at least one quality control
(rs12634530, rs12637456, and rs13075202) or that could
not be genotyped (rs1444754) using the iPlex assay were gen-
otyped using the TaqMan allelic discrimination assays
(assays-on-demand C__11236577_10, C__11236574_10,
C___1720000_10, and C___9532531_10, respectively)
from Applied Biosystems (Foster City, USA). Even though
SNP rs13075202 was out of HWE in the control dataset
(P < 0.05), it was considered for further analysis as it was
genotyped consistently in two assays (iPlex and assay-on-
demand) and passed all other quality checks. All the geno-
typing was performed in the Genomics Unit of the Instituto
Gulbenkian de Ciência.
Statistical analysis
An unpaired Student’s t test and a 2 test were used to com-
pare quantitative and qualitative clinical and demographic
data, respectively, between cases and controls. 2 tests for
HWE, allelic association of SNPs with IS risk, and linkage
disequilibrium (LD) plots were performed using Haploview
4.0 (Barrett et al. 2005).
The genotypic association between IS and each SNP
was examined by logistic regression analyses using the
SNPassoc v.1.4-9 package (González et al. 2007) imple-
mented in the R freeware (http://cran.r-project.org/). To
adjust the association analyses for relevant confounding
factors, hypertension, diabetes, and ever smoking were
included as covariates in multivariate logistic regression
with backward elimination of risk factors. The interaction i
among these covariates in regression models was not
strong (¡0.5 < i < 0.5). Odds ratios (ORs) and their associ-
ated 95% conWdence intervals (CIs) were uncorrected for
confounding variables in the 2 tests and unadjusted logis-
tic regression, and corrected for covariates in adjusted
regression models. Results were considered signiWcant
below the conventional level of 0.05. Since there is LD
among some of the genotyped SNPs, we did not perform
corrections for multiple testing, and uncorrected P values
are reported.
Imputation
Ungenotyped SNPs in chromosome 3 were imputed with
PLINK v1.04 (Purcell et al. 2007) using HapMap data
(Release 22, 154783 SNPs in chromosome 3 with MAF
greater than 0.01 and genotyping rate greater than 0.95 in
the 60 CEU founders). For every imputed SNP, PLINK
provides an information content metric INFO, ranging from
0 to 1 (although it can be greater than 1 occasionally). A
higher INFO value generally means a better SNP imputa-
tion. All imputed SNPs with MAF in controls smaller than
0.05 and with INFO < 0.5 were excluded. For SNPs that
have been genotyped, PLINK calculates the concordance
rate among observed and imputed genotypes.
To conWrm the imputation results, three imputed SNPs
(rs7620580, rs6438833, and rs11712039) signiWcantly
associated with IS were fully genotyped in our case–
control biobank, and tested for association as described
previously.
Results
Table 1 summarizes the principal characteristics of the
dataset used in this study. The average age at the Wrst stroke
is 51.7 § 9.5 years. Since stroke is a late-onset disease, we
chose to have the control group signiWcantly older than the
case group to minimize misclassiWcation biases. As
expected, male:female ratio, hypertension, diabetes, ever
smoking, and ever drinking were signiWcantly higher in IS
patients than in controls.123
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(Table 2), originally found associated with CAD in the
CATHGEN initial dataset (SNPs 2, 3, 4, 7, 8, 9, 12, 14, 20,
22, 31, and 37 in Wang et al. 2007), which includes the
rs4234218 (SNP 31 in Wang et al. 2007) associated with
cardiovascular risk, T2D, and MS (Rudock et al. 2008).
These polymorphisms are located in ROPN1, ROPN1–
KALRN intergenic region and in the 5 region of the
KALRN gene. In our dataset, all of these polymorphisms are
also haplotype tagging SNPs, with the exception of
rs7613868 and rs12637456 (SNPs 7 and 9, respectively, in
Wang et al. 2007) which are in almost complete LD
(r2 = 0.97; Fig. 1).
We found that a cluster of SNPs in low LD (pairwise
r2 · 0.56) in the ROPN1–KALRN intergenic region
(rs4499545, rs7613868/rs12637456, and rs12634530) was
associated with IS in allelic and unadjusted genotypic tests
(Fig. 1; Supplementary Table 1). The association of SNP
rs4499545 remained signiWcant after adjustment for covari-
ates (P = 0.028, OR [95% CI] = 1.31 [1.03–1.67]).
rs9289231, which has been associated with early-onset
CAD and atherosclerosis burden in human aortas (Wang
et al. 2007) and rs4234218 were not associated with IS in
any test performed (Fig. 1).
Given the evidence for association of genetic variants in
the ROPN1–KALRN region with IS, although with a diVer-
ent variant than previously reported to be associated with
cardiovascular risk, we decided to further investigate this
region by analyzing additional SNPs. We genotyped 22
additional haplotype tagging SNPs in the ROPN1 region,
the ROPN1–KALRN intergenic region, and in the 5 region
of KALRN (Table 2). Since the KALRN gene is extremely
large, we chose to concentrate our eVorts on the KALRN
region with the reported associations.
Two newly analyzed SNPs in the ROPN1–KALRN inter-
genic region LD block (rs2280422 and rs2332719) and two
SNPs in KALRN (rs17377867 and rs6784664) were associ-
ated (0.003 < P < 0.042) in allelic and unadjusted log-addi-
tive model tests, but these associations became marginal
(0.05 < P < 0.15) when adjusted for covariates (Fig. 1; Sup-
plementary Table 1). Inclusion of any combination of two
of these covariates had the same overall eVect, but it is not
always the same polymorphisms that become marginally
signiWcant, suggesting that this may be mostly a power
issue and not a biologically relevant phenomenon. On the
other hand, two new SNPs in KALRN (rs17286604 and
rs11712619) demonstrated association in all tests per-
formed (Fig. 1; Supplementary Table 1).
Table 3 presents more detailed association results for
the three genotyped SNPs demonstrating an association
with IS in all tests performed (rs4499545, rs17286604,
and rs11712619). Similar to the rs4234218 association
with cardiovascular risk, T2D, and MS (Rudock et al.
2008), the most signiWcant results for these three SNPs
were under the dominant genetic model (Table 3). These
polymorphisms are in very low LD (all pairwise r2 < 0.34
and D < 0.58). SNP rs4499545 remains signiWcantly
associated when the other two markers are used as covari-
ates, while the association subsides for rs11712619 when
adjusted for rs17286604. These data suggest at least two
independent lines of evidence for association of KALRN
with IS.
Even though we investigated 23 haplotype tagging SNPs
in the 5 end of KALRN, a large portion of its natural
genetic variation was not assessed because it is a very large
gene with a high degree of genetic diversity. We therefore
performed genotype imputation for SNPs in chromosome 3
using data from HapMap as well as the genotypes observed
at the 34 fully genotyped polymorphisms. We obtained
imputed genotypes meeting minimum quality standards
(MAF in controls ¸ 0.05 and SNP INFO ¸ 0.5) for 405
SNPs in and around ROPN1 and KALRN (Fig. 2). As
expected, the imputed SNPs with higher information con-
tent metric (SNP INFO > 0.8) are located in the region of
genotyped SNPs. As an additional quality control, the gen-
otyped SNPs are dropped one at a time and imputed using
the other observed genotypes. A concordance rate between
observed and imputed genotypes can be calculated for these
markers, and 90% of the genotyped SNPs had a concor-
dance rate >85% between imputed and observed genotypes
(Fig. 2). Thirty-two of the imputed polymorphisms have an
allelic association with IS risk at a more stringent P threshold
Table 1 General characteristics of the ischemic stroke case–control
study sample
SD standard deviation
a P of an unpaired Student’s t test or a 2 test for quantitative and qual-
itative data, respectively
Characteristic Controls Cases Pa
N 517 565
Sex (n/N, % male) 238/517 (46.0) 361/565 (63.9) <10¡4
Age-at-examination 
(mean § SD, years)
63.0 § 6.8 52.4 § 9.3 <10¡4
Age-at-onset 
(mean § SD, years)
– 51.7 § 9.5 –
Risk factors (n/N, %)
Hypertension 
(>140–85 mmHg)
192/508 (37.8) 289/505 (57.2) <10¡4
Hypercholesterolemia 
(>200 mg/dL)
324/515 (62.9) 328/526 (62.4) 0.853
Hypertriglycemia 
(>200 mg/dL)
68/437 (15.6) 42/229 (18.3) 0.359
Diabetes 57/496 (11.5) 95/538 (17.7) 0.005
Ever smoking 146/507 (28.8) 272/556 (48.9) <10¡4
Ever drinking 218/500 (43.6) 326/558 (58.4) <10¡4123
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Wve SNPs (P · 0.001), the Wrst one (rs6790975) has a mod-
est SNP INFO metric (0.598), and therefore its association
has to be taken with caution, but the remaining four mark-
ers (rs4678111, rs7620580, rs9820396, and rs1444770)
have a very high SNP INFO metric (0.93) and are in com-
plete LD (Fig. 2). The LD among the top 32 imputed asso-
ciated SNPs (Fig. 2) also suggests the existence of several
independent clusters of association with IS in the 5 region
of the KALRN gene, such as the rs6438833–rs1373612,
rs6779809–rs11712039–rs11719349 and rs4678111–
rs7620580-rs9820396–rs1444770 clusters.
To validate the imputation results, we additionally geno-
typed in our dataset three SNPs (rs6438833, rs11712039,
and rs4678111) representing the abovementioned clusters
of association (highlighted in light gray in Table 2), and
tested their association with IS. The average concordance
rate among observed and imputed genotypes was 92%. All
Table 2 Characteristics of the 
investigated SNPs
The 12 SNPs that were Wrst gen-
otyped are highlighted in dark 
gray and the three SNPs that 
were genotyped to validate the 
imputation results are high-
lighted in light gray
a I iPlex; T TaqMan
b rs4499545 is the current name 
for SNP rs7434266123
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Supplementary Table 1).
Among the SNPs tested and associated with IS in this
study, SNP rs11712039 has also been associated with IS
(0.001 < P < 0.01) in the Ikram et al. (2009) IS GWAS, as
shown in Supplementary Table 1. rs17286604 and
rs11712619, which are associated with IS in our Portuguese
sample, were modestly associated in the GWAS, and SNP
rs4499545 has not been tested (Supplementary Table 1).
Discussion
In this study, we highlight for the Wrst time an association
of the Kalirin gene with risk for ischemic stroke. Given that
KALRN has already been implicated in susceptibility to car-
diovascular disorders and some of its risk factors (e.g. T2D)
(Wang et al. 2007; Rudock et al. 2008; Ikram et al. 2009),
we propose that Kalirin may constitute a novel genetic risk
factor for vascular phenotypes.
Kalirin is an extremely complex gene generating many
alternative transcripts under the control of several promot-
ers in a tissue-speciWc and developmentally regulated man-
ner (McPherson et al. 2004; Johnson et al. 2000; Ma et al.
2001) encoding multidomain and multifunctional proteins
(McPherson et al. 2002). A number of recent studies have
demonstrated that Kalirin-7, the most abundant isoform in
adult brain (Penzes et al. 2000), is involved in dendritic
spine development, plasticity, and stability (Penzes and
Jones 2008). Kalirin-7 gene transcripts are underexpressed
in Alzheimer’s disease (AD) hippocampal specimens
(Youn et al. 2007a), and underexpression of Kalirin-7
increases iNOS (inducible nitric oxide (NO) synthase)
activity in cultured cells and correlates with increased
iNOS activity in AD hippocampus (Youn et al. 2007b).
Interestingly, Kalirin is known to associate with iNOS in
vitro and in vivo and to prevent iNOS dimerization, and
therefore iNOS activity (Ratovitski et al. 1999). NO, a
potent cell-signaling, eVector, and vasodilator molecule
characterized by its strong reactivity and diVusibility, is
produced in a complex and tightly controlled process by
three NO synthases: iNOS, neuronal synthase (nNOS), and
endothelial synthase (eNOS). Cytokines, endotoxin, or
other proinXammatory stimuli induce iNOS expression in
Fig. 1 Association results and 
pairwise linkage disequilibrium 
(LD) among all genotyped poly-
morphisms. Allelic (black 
squares) as well as crude (green 
disks) and adjusted (red trian-
gles) genotypic (log-additive 
model) association results are 
shown. Odds ratios (ORs) and 
95% conWdence intervals (CIs) 
are depicted with stars and bars 
for signiWcantly associated 
(P < 0.05) polymorphisms. In 
the LD plot, the white–black 
gradient shading within each 
diamond represents the magni-
tude of LD using the pairwise 
LD statistic r2 (from lower to 
higher values, respectively). The 
positions of the SNPs relative to 
the ROPN1 and KALRN genes 
are indicated. Boxes surrounding 
SNP names indicate the 12 poly-
morphisms that we Wrst geno-
typed123
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SNP
Model
Controls 
(%)
Cases 
(%)
Unadjusted Adjusted
OR [95% CI] P OR [95% CI] P
rs4499545
Codominant 1/1 69.4 61.5 1.00 0.022 1.00 0.055
1/2 26.4 34.2 1.46 [1.11–1.91] 1.43 [1.06–1.93]
2/2 4.2 4.3 1.14 [0.62–2.10] 1.33 [0.67–2.65]
Dominant 1/1 69.4 61.5 1.00 0.008 1.00 0.016
1/2–2/2 30.6 38.5 1.42 [1.09–1.83] 1.42 [1.07–1.89]
Recessive 1/1–1/2 95.8 95.7 1.00 0.974 1.00 0.615
2/2 4.2 4.3 1.01 [0.55–1.85] 1.19 [0.60–2.35]
log-Additive 0, 1, 2 1.28 [1.03–1.59] 0.026 1.31 [1.03–1.67] 0.028
rs6438833
Codominant 1/1 78.3 85.2 1.00 0.016 1.00 0.042
1/2 19.0 13.7 1.51 [1.06–2.16] 1.49 [1.01–2.21]
2/2 2.6 1.1 2.70 [0.93–7.85] 2.58 [0.77–8.60]
Dominant 1/1 78.3 85.2 1.00 0.007 1.00 0.018
1/2–2/2 21.7 14.8 1.60 [1.13–2.25] 1.57 [1.08–2.28]
Recessive 1/1–1/2 97.4 98.9 1.00 0.076 1.00 0.136
2/2 2.6 1.1 2.52 [0.87–7.32] 2.41 [0.72–8.04]
log-Additive 0, 1, 2 1.55 [1.14–2.101 0.004 1.53 [1.09–2.13] 0.012
rsl7286604
Codominant 1/1 38.9 47.9 1.00 0.011 1.00 0.028
1/2 49.5 41.5 0.68 [0.53–0.88] 0.68 [0.51–0.90]
2/2 11.6 10.6 0.74 [0.50–1.11] 0.80 [0.52–1.23]
Dominant 1/1 38.9 47.9 1.00 0.003 1.00 0.010
1/2–2/2 61.1 52.1 0.69 [0.54–0.88] 0.70 [0.54–0.92]
Recessive 1/1–1/2 88.4 89.4 1.00 0.613 1.00 0.898
2/2 11.6 10.6 0.91 [0.62–1.33] 0.97 [0.65–1.47]
log-Additive 0, 1, 2 0.80 [0.67–0.96] 0.014 0.82 [0.67–1.00] 0.049
rsll712039
Codominant 1/1 46.2 39.0 1.00 0.022 1.00 0.070
1/2 45.8 48.5 0.79 [0.60–1.05] 0.84 [0.62–1.13]
2/2 8.0 12.5 0.54 [0.34–0.86] 0.56 [0.34–0.93]
Dominant 1/1 46.2 39.0 1.00 0.027 1.00 0.093
1/2–2/2 53.8 61.0 0.74 [0.57–0.97] 0.78 [0.59–1.04]
Recessive 1/1–1/2 92.0 87.5 1.00 0.026 1.00 0.045
2/2 8.0 12.5 0.61 [0.39–0.95] 0.61 [0.38–1.00]
log-Additive 0, 1, 2 0.76 [0.62–0.93] 0.007 0.78 [0.63–0.97] 0.027
rs11712619
Codominant 1/1 38.4 47.0 1.00 0.010 1.00 0.050
1/2 49.8 44.5 0.73 [0.57–0.94] 0.78 [0.59–1.03]
2/2 11.8 8.4 0.58 [0.38–0.89] 0.60 [0.37–0.95]
Dominant 1/1 38.4 47.0 1.00 0.004 1.00 0.030
1/2–2/2 61.6 53.0 0.70 [0.55–0.9] 0.74 [0.57–0.97]
Recessive 1/1–1/2 88.2 91.6 1.00 0.068 1.00 0.087
2/2 11.8 8.4 0.69 [0.46–1.03] 0.68 [0.43–1.06]
log-Additive 0, 1, 2 0.75 [0.62–0.91] 0.003 0.77 [0.63–0.95] 0.014123
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tively expressed primarily in neural tissue and endothelium,
respectively, which are the principal tissues involved in
stroke. Several published case–control studies describe an
association of genetic variants in eNOs with ischemic
stroke risk (Domingues-Montanari et al. 2008), and we
have found an association of nNOS with IS (personal com-
munication). Kalirin-7 is involved in the regulation of
ischemic signal transduction (Beresewicz et al. 2008), and
may play a neuroprotective role during inXammation of the
central nervous system by inhibiting iNOS activity (Rato-
vitski et al. 1999). It would therefore be interesting to
assess the role played by genetic variation in Kalirin in
stroke severity and recovery, as well as epistatic eVects
between KALRN and NO synthases in ischemic stroke risk.
Several independent Kalirin polymorphisms have now
been associated in previous studies (Wang et al. 2007;
Rudock et al. 2008; Ikram et al. 2009) and in the present
report with vascular phenotypes, and therefore it is not
clear which is(are) the exact susceptibility variant(s). Kali-
rin appears to be a pleiotropic protein, and it is possible that
diVerent variants in the same gene cause related pheno-
types. Alternatively, the causal polymorphism might not
have been directly studied yet, as suggested by our imputa-
tion approach. Given that we had genotyped a relatively
high number of haplotype tagging SNPs in the KALRN
gene region, we were able to impute hundreds of neighbor-
ing polymorphisms with high conWdence and identiWed
many SNPs with stronger association than those directly
genotyped. Genomewide imputation is currently performed
routinely in whole-genome association studies to increase
power, but “local” imputation may also be a powerful
approach to detect novel associations when there is a dense
map of observed genotypes. We validated this local imputa-
tion approach in our dataset through direct genotyping.
Another possibility is that Kalirin demonstrates an even
stronger association with a pathogenic mechanism (e.g.
inXammation) or subtype (e.g. small vessel) of vascular dis-
ease that has not yet been tested directly or corrected for in
the statistical analyses. This hypothesis is supported by the
signiWcant increase in the evidence for linkage at 3q13
(LOD = 5.10, P = 0.008) in GENECARD families with
lower-risk lipid proWles and fewer known risk factors (Shah
et al. 2006). We did not test the association of Kalirin with
IS subtypes since a much larger sample size would be
required to have a representative number of individuals in
each subtype and genotype category.
Population stratiWcation was a frequent confounding fac-
tor in previous association studies. It can be corrected for
when genomewide data is available, but is harder to address
in candidate gene studies when no ancestry-informative
markers are known. Population genetic studies with very
large numbers of autosomal markers have never been con-
ducted in self-described Portuguese Caucasians. Addition-
ally, there are no major historical events that lead us to
suspect that a signiWcant proportion of Portuguese Cauca-
sian individuals are of mixed backgrounds. Therefore, we
do not expect that an underlying population substructure in
our sample accounts for the observed associations.
The type of correction for multiple testing that must be
employed is subject to controversy, but our positive associ-
ation Wndings would not survive the most conservative
Bonferroni correction. However, replication in multiple
independent datasets remains the gold-standard of associa-
tion studies, even for modest associations. Our study high-
lights the importance of replicating associations that fall
below the genomewide signiWcance threshold. These vari-
ants may account for part of the missing heritability.
We believe that the Kalirin association is promising
because of the multiple independent lines of evidence for
Table 3 continued
Unadjusted (without covariates) and adjusted (for hypertension, diabetes, and ever smoking) association testings were performed using diVerent
models (codominant, dominant, recessive, and log-additive). SigniWcant P values are shown in bold
OR odds ratio, CI conWdence interval
SNP
Model
Controls 
(%)
Cases 
(%)
Unadjusted Adjusted
OR [95% CI] P OR [95% CI] P
rs7620580
Codominant 1/1 70.4 78.6 1.00 0.019 1.00 0.020
1/2 26.7 19.5 1.52 [1.11–2.09] 1.58 [1.13–2.23]
2/2 2.9 1.9 1.72 [0.72–4.14] 1.72 [0.68–4.35]
Dominant 1/1 70.4 78.6 1.00 0.005 1.00 0.005
1/2–2/2 29.6 21.4 1.54 [1.14–2.09] 1.60 [1.15–2.22]
Recessive 1/1–1/2 97.1 98.1 1.00 0.317 1.00 0.355
2/2 2.9 1.9 1.56 [0.65–3.73] 1.54 [0.61–3.87]
log-Additive 0, 1, 2 1.45 [1. 11–1.90] 0.006 1.49 [1. 12–1.98] 0.007123
Hum Genet (2010) 127:513–523 521Fig. 2 Association results of imputed SNPs. The top plot displays the
negative logarithm of the P for the allelic association test of all 405 im-
puted SNPs in chromosome 3. The second plot shows the SNP infor-
mation content metric SNP INFO, and the third plot displays the
concordance rate of observed and imputed genotypes (for genotyped
SNPs only). In all plots, the 32 imputed SNPs with P < 0.01 are repre-
sented with red spheres, and the 34 SNPs that have been genotyped are
represented with green squares. Known genes in this region are indi-
cated (MYLK myosin light chain kinase isoform; CCDC14 coiled-coil
domain containing 14). The LD plot at the bottom shows all the pair-
wise correlation coeYcients (r2) among the 32 imputed SNPs with
P < 0.01
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522 Hum Genet (2010) 127:513–523association, namely the association of several uncorrelated
SNPs, the replication of the most associated SNP results on
the Ikram et al. (2009), GWAS published study, and the
previous reports of association with cardiometabolic syn-
drome (Wang et al. 2007; Rudock et al. 2008). Additional
replication studies in other independent datasets with stroke
and vascular pathologies are needed to further conWrm
Kalirin’s role in vascular disease susceptibility. Deep
sequencing may have to be used to precisely identify the
causal genetic variant.
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